Marks’ resignation leaves the field without a regulator many view as “integral” to its progress over the last decade.
Dr. Peter Marks announced his resignation from the U.S. Food and Drug Administration (FDA) as Director of CEBR (Center for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback